Information Provided By:
Fly News Breaks for February 24, 2020
CYH
Feb 24, 2020 | 09:02 EDT
RBC Capital analyst Frank Morgan raised his price target on Community Health to $8 after its Q4 earnings beat, saying the company's portfolio rationalization and operational improvement initiatives are gaining traction. The analyst also believes that the tailwinds from strong Medicare rate update should support its EBITDA growth of about 6%. Morgan notes however that the company's relatively high leverage and uncertainty around its turnaround process warrant a maintained Sector Perform rating.
News For CYH From the Last 2 Days
CYH
Apr 25, 2024 | 07:41 EDT
Oppenheimer lowered the firm's price target on Community Health to $4.50 from $5.50 and keeps an Outperform rating on the shares following quarterly results. The firm notes Community Health maintained its 2024 outlook. Overall, at these levels, Oppenheimer continues to see attractive upside for long-term investors.
CYH
Apr 24, 2024 | 16:23 EDT
Reports Q1 revenue $3.14B, consensus $3.09B. On a same-store basis, admissions increased 3.8% and adjusted admissions increased 1.9%, compared to the same period in 2023. The company said, "We were pleased with our first quarter performance compared to both prior year and prior quarter. Progress was demonstrated on key operational and strategic priorities, and we remain focused on building further momentum as we pursue the opportunities available to us this year"